Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 14 Neoplasm Metastasis 6 Kidney Neoplasms 5 Breast Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Glioblastoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Uveal Melanoma 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Hormone Refractory Prostate Cancer 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Fatigue 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Carcinoid Tumor 1 Brain Neoplasms 1

Interventions

Doxorubicin 19 Radiotherapy 10 Ifosfamide 10 apatinib 9 anlotinib 8 Cyclophosphamide 8 camrelizumab 7 Vincristine 5 Dactinomycin 5 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Etoposide 3 Docetaxel 3 ribociclib 2 brostallicin 2 Topotecan 2 Thalidomide 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Neoadjuvant Therapy 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Gene Expression Profiling 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × Sunitinib × Clear all

NCT00753727 2011-06-23

SUNXRT

Australasian Sarcoma Study Group

Phase 1/2 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡